| Dr Quang T Nguyen, MD | |
|
433 E 8th St, Port Angeles, WA 98362-6219 | |
| (360) 565-0999 | |
| (360) 452-7303 |
| Full Name | Dr Quang T Nguyen |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 433 E 8th St, Port Angeles, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942220520 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Olympic Medical Center | Port angeles, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Olympic Medical Physicians | 9537172358 | 113 |
| Legacy Clinics Llc | 0244144004 | 603 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
A new analysis of 12 long-term studies published since 2008 from across the globe finds that young people under the legal drinking age who are more exposed to alcohol marketing appear more likely to start drinking early and also to engage in binge drinking.
› Verified 8 days ago
| Entity Name | Whidbey Island Public Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710927231 PECOS PAC ID: 1658280680 Enrollment ID: O20040210000761 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
A new analysis of 12 long-term studies published since 2008 from across the globe finds that young people under the legal drinking age who are more exposed to alcohol marketing appear more likely to start drinking early and also to engage in binge drinking.
› Verified 8 days ago
| Entity Name | Olympic Medical Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427081967 PECOS PAC ID: 9537172358 Enrollment ID: O20060721000246 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
A new analysis of 12 long-term studies published since 2008 from across the globe finds that young people under the legal drinking age who are more exposed to alcohol marketing appear more likely to start drinking early and also to engage in binge drinking.
› Verified 8 days ago
| Entity Name | Capital Medical Center Specialty Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760785281 PECOS PAC ID: 2567651771 Enrollment ID: O20110104000592 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
A new analysis of 12 long-term studies published since 2008 from across the globe finds that young people under the legal drinking age who are more exposed to alcohol marketing appear more likely to start drinking early and also to engage in binge drinking.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Quang T Nguyen, MD Po Box 850, Port Angeles, WA 98362-0146 Ph: (360) 565-0999 | Dr Quang T Nguyen, MD 433 E 8th St, Port Angeles, WA 98362-6219 Ph: (360) 565-0999 |
News Archive
Sosei Group Corporation announce the commencement of the Phase III clinical programme by Novartis, with QVA149, a once-daily, dry powder bronchodilator for inhalation combining a fixed dose of the once-daily beta2-agonist QAB149 (indacaterol) and the long-acting muscarinic antagonist NVA237 (glycopyrronium bromide) for the treatment of chronic obstructive pulmonary disease (COPD). The start of Phase III triggers a $7.5m milestone payment to Sosei.
According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.
Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.
A new analysis of 12 long-term studies published since 2008 from across the globe finds that young people under the legal drinking age who are more exposed to alcohol marketing appear more likely to start drinking early and also to engage in binge drinking.
› Verified 8 days ago
Oksana Y Shklyanka, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St # 3e, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-452-7303 | |
Alford Nathaniel Vassall Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St Ste A, Port Angeles, WA 98362 Phone: 360-655-0999 Fax: 360-452-7303 | |
Mr. Stephen D Bush, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St # 3e, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-452-7303 | |
Sheena Plamoottil, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 907 Georgiana St, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-452-7303 | |
Dr. Gretchen A Heinrichs, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 433 E 8th St, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-452-7303 |